Kurkitt's lymphoma in a carrier of Wegener's granulomatosis

Authors

  • Kryssia Rodríguez Castro Caja Costarricense del Seguro Social, Hospital México
  • Henry Zamora Barquero Caja Costarricense del Seguro Social, Hospital México

DOI:

https://doi.org/10.51481/amc.v47i4.209

Keywords:

Weneger's granulomatosis, Burkit's lymphoma, lymphoproliferative disorders

Abstract

This is a report of a costarrican male with Wegener'sgranulomatosis undergoing treatment with prednisone andcyclophosphamide, he developed a fatal Burkitt s lymphoma. The possible relationship between these two disor-ders is addressed.

Downloads

Download data is not yet available.

References

Cos S, Harper L, Cockwell P, Adu D, Howie AJ. ABC of arterial andvascular disease: Vasculitis. BMJ 2000; 320: 1325-28.

Talar-Williams C, Hijazi YM, WM McClellan, Linehan MW,Hallahan CW, Lubensky I, Kerr GS, Hoffman GS, Fauci AS, SnellerMS. Cyclophosphamide-Induced Cystitis and Bladder Cancer inPatients with Wegener Granulomatosis Ann Intern Med, 1996; 124:477-484.

Blundell AG, Roe S. Wegener's granulomatosis presenting as a pleu-ral effusion. BMJ, 2003; 327: 95-96.

Uppal S, Saravanappa N, Davis JP, Farmer CKT, Goldsmith DJA.Lesson of the week: Pulmonary Wegener's granulomatosis misdiag-nosed as malignancy. BMJ, 2001; 322: 89-90. 5.Daily J P, Sadeghi S. A 35-Year-Old Man with a Painful AbdominalMass and Fever. N Engl J Med 2000; 342:493-500.

Isaacson P G. Gastrointestinal lymphomas of T- and B-cell types.Mod Pathol 1999;12:151-158.

Practice Guidelines in Oncology. National Comprehensive CancerNetwork Version 1.2005 http://www.nccn.org/professionals/physi-cian_gls/PDF/nhl.pdf

Jaffe E S. Hematopathology: Integration of morphologic features andbiologic markers for diagnosis. Mod Pathol 1999; 12:109-115.

Ramos-Casals M, Trejo O, García-Carrasco M, Cervera R, De la RedG, Gil V, López-Guillermo A, Ingelmo M, Font J. Triple AssociationBetween Hepatitis C Virus Infection, Systemic AutoimmuneDiseases, and B Cell Lymphoma. J Rheumatol 2004; 31:495-9.

Groves FD, Linet MS, Travis LB, Devesa SS. Cancer Surveillance Series: Non-Hodgkin's Lymphoma Incidence byHistologic Subtype in the United States From 1978 Through 1995. JNatl Cancer Inst 2000; 92: 1240-1251.

Ambrus J L, Fauci A S. Diffuse histiocytic lymphoma in a patienttreated with cyclophosphamide for Wegener s Granulomatosis. Am JMed. 1984;76:145-747.

Colburn K K, Cao J D, Krick E H, Mortensen S E, Wong L G.Hodgkin s lymphoma in a patient treated for Wegener sGranulomatosis with cyclophosphamide and azatiophrine. JRheumatol 1985;12:599-602.

Louie S, Daoust P R, Schwartz R S. Immunodeficiency and thepathogenesis of non-Hodgkin s lymphoma. Semin Oncol.1980;7:267-284.

Knowles D M. Immunodeficiency-Associated lymphoproliferativedisorders. Mod Pathol 1999;12:200-217.

Thompson M P, Kurzrock R. Epstein-Barr virus and cancer. ClinCancer Res 2004,10;803-821.

Chabay P A, De Matteo E N, Aversa L, Maglio S. Grinstein S,Preciado M V. Assessment of Epstein-Barr Virus Association WithPediatric Non-Hodgkin Lymphoma in Immunocompetent and inImmunocompromised Patients in Argentina. Arch Pathol Lab Med.2002;126:331-5.

Downloads

Published

2005-10-01

How to Cite

Kurkitt’s lymphoma in a carrier of Wegener’s granulomatosis. (2005). Acta Médica Costarricense , 47(4), 199-201. https://doi.org/10.51481/amc.v47i4.209